Stock OPTN OPTINOSE, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Analyst Reco. OptiNose, Inc.

Equities

OPTN

US68404V1008

Delayed Nasdaq
Other stock markets
 03:59:51 2024-06-10 pm EDT 		5-day change 1st Jan Change
1.17 USD +10.38% Intraday chart for OptiNose, Inc. +7.80% -8.91%
May. 20 OptiNose, Inc. announced that it has received $4.68 million in funding CI
May. 14 Transcript : OptiNose, Inc., Q1 2024 Earnings Call, May 14, 2024

Analyst Reco.

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Lake Street Adjusts Price Target on OptiNose to $4 From $3, Maintains Buy Rating
MT
HC Wainwright Initiates OptiNose With Buy Rating, $5 Price Target
MT
Lake Street Initiates OptiNose at Buy Rating With $3 Price Target
MT
BMO Capital Adjusts Price Target on OptiNose to $5 From $6, Maintains Outperform Rating
MT
Jefferies Assumes OptiNose at Buy with $5 Price Target
MT
OPTINOSE : RBC Cuts Price Target on OptiNose to $10 From $17 on Lower Long-Term Sales Estimates; Outperform-Speculative Risk Rating Kept
MT
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. OPTN Stock
  4. News OptiNose, Inc.
  5. Analyst Reco.